
Lupin Limited has informed the Exchange regarding a press release dated October 31, 2023, titled "Lupin Receives EIR from U.S. FDA for its Mandideep Unit-2 Manufacturing Facility".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated October 31, 2023, titled "Lupin Receives EIR from U.S. FDA for its Mandideep Unit-2 Manufacturing Facility".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin